AGH Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$499K Sell
996
-1
-0.1% -$480 0.32% 64
2026
Q1
$490K Sell
997
-35
-3% -$19K 0.36% 59
2025
Q4
$598K Sell
1,032
-6
-0.6% -$3.39K 0.45% 44
2025
Q3
$503K Buy
1,038
+186
+22% +$86.6K 0.37% 58
2025
Q2
$345K Sell
852
-134
-14% -$56K 0.28% 73
2025
Q1
$491K Sell
986
-132
-12% -$71.5K 0.47% 45
2024
Q4
$582K Buy
+1,118
New +$615K 0.54% 40

Other funds holding TMO

AGH Wealth Advisors's TMO Position: Q2 2026 in Review

AGH Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.1% in Q2 2026, selling an estimated $480 and leaving 996 shares worth $499K. The position accounts for 0.32% of the portfolio, ranked #64.

AGH Wealth Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $598K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • AGH Wealth Advisors held 996 shares of Thermo Fisher Scientific worth $499K as of Q2 2026.
  • AGH Wealth Advisors sold 1 Thermo Fisher Scientific share in Q2 2026, an estimated $480.
  • Thermo Fisher Scientific made up 0.32% of AGH Wealth Advisors's portfolio in Q2 2026, its #64 holding.
  • AGH Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • AGH Wealth Advisors's Thermo Fisher Scientific position peaked at $598K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on AGH Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.